New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct-acting antiviral therapy (DAAs) in patients with chronic hepatitis C: Evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM
Titel:
New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct-acting antiviral therapy (DAAs) in patients with chronic hepatitis C: Evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM
Auteur:
Cespiati, A. Petta, S. Lombardi, R. Di Marco, V. Calvaruso, V. Bertelli, C. Pisano, G. Fatta, E. Sigon, G. Iuculano, F. Crapanzano, L. Gibilaro, G. Francione, P. Craxì, A. Fargion, S. Fracanzani, A.L.